289 related articles for article (PubMed ID: 15880131)
1. Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Koharazawa H; Kanamori H; Takabayashi M; Yamaji S; Taguchi J; Fujimaki K; Ishigatsubo Y
Bone Marrow Transplant; 2005 Jun; 35(12):1223-4. PubMed ID: 15880131
[No Abstract] [Full Text] [Related]
2. Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran.
Ghavamzadeh A; Iravani M; Jabehdar-Maralani P; Hajrasouliha A; Tavakoli S
Haematologica; 2003 Apr; 88(4):ELT13. PubMed ID: 12681990
[No Abstract] [Full Text] [Related]
3. Separation of graft-vs.-host disease and graft-vs.-leukemia effect against chronic myelogenous leukemia.
Champlin R
Exp Hematol; 1995 Oct; 23(11):1148-51. PubMed ID: 7556522
[No Abstract] [Full Text] [Related]
4. Liver nodular regenerative hyperplasia after bone marrow transplant.
Pezzullo L; Muretto P; De Rosa G; Picardi M; Lucania A; Rotoli B
Haematologica; 2000 Jun; 85(6):669-70. PubMed ID: 10870131
[No Abstract] [Full Text] [Related]
5. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
[No Abstract] [Full Text] [Related]
6. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
[TBL] [Abstract][Full Text] [Related]
7. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
Hirokawa M; Kume M; Wu T; Ishikawa K; Sawada KI
Bone Marrow Transplant; 2006 Sep; 38(5):387-8. PubMed ID: 16862163
[No Abstract] [Full Text] [Related]
8. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.
Reynaert H; De Coninck A; Neven AM; Van Camp B; Schots R
Bone Marrow Transplant; 1992 Aug; 10(2):185-7. PubMed ID: 1388082
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic blood stem cell transplantation in advanced chronic myeloid leukemia--high response rate associated with increased chronic graft-versus-host disease.
Sayer HG; Kasper C; Mügge LO; Schilling K; Scholl S; Höffken K
Haematologica; 2003 Jul; 88(7):831-3. PubMed ID: 12857566
[No Abstract] [Full Text] [Related]
11. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
Kanamori H; Tanaka M; Kawaguchi H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
Am J Hematol; 2002 Sep; 71(1):41-4. PubMed ID: 12221673
[TBL] [Abstract][Full Text] [Related]
12. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation.
Cereda M; Trocino G; Pogliani EM; Schiavina R
Ital Heart J; 2003 Jan; 4(1):60-3. PubMed ID: 12690924
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
Transplant Proc; 1995 Dec; 27(6):3531-2. PubMed ID: 8540086
[No Abstract] [Full Text] [Related]
14. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
Adkins DR; Abidi MH; Brown RA; Khoury H; Goodnough LT; Vij R; Westervelt P; DiPersio JF
Bone Marrow Transplant; 2000 Dec; 26(11):1239-41. PubMed ID: 11149740
[TBL] [Abstract][Full Text] [Related]
15. Use of an anti-interleukine 2 receptor monoclonal antibody for GvHD prophylaxis in unrelated bone marrow transplantation. GEGMO Group.
Belanger C
Bone Marrow Transplant; 1993; 11 Suppl 1():112-3. PubMed ID: 8448532
[No Abstract] [Full Text] [Related]
16. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
[TBL] [Abstract][Full Text] [Related]
17. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
Przepiorka D; Gonzales-Chambers R
Bone Marrow Transplant; 1990 Oct; 6(4):281-2. PubMed ID: 2085702
[TBL] [Abstract][Full Text] [Related]
18. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
19. Spontaneous pneumomediastinum in a patient with bronchiolitis obliterans after bone marrow transplantation.
Galanis E; Litzow MR; Tefferi A; Scott JP
Bone Marrow Transplant; 1997 Oct; 20(8):695-6. PubMed ID: 9383235
[TBL] [Abstract][Full Text] [Related]
20. Timing of allogeneic BMT for CML patients in India: does it affect response?
Sazawal S; Hasan SK; Kumar B; Kumar R; Kumar L; Saxena R
Am J Hematol; 2007 Apr; 82(4):329. PubMed ID: 16947319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
